DeepMed Research

Northwestern University Human Resources

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-28

Employees: 5K

Market Cap: -

Website: https://www.venturecat.northwestern.edu

Clinical Trials

Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer

Completed

Conditions: Liver Cancer
Metastatic Cancer

First Posted Date: 2008-08-21

Last Posted Date: 2015-10-16

Lead Sponsor: Northwestern University

Target Recruit Count: 74

Registration Number: NCT00739167

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone

Phase 3

Completed

Conditions: Type 2 Diabetes
Obesity

Interventions: Behavioral: Lifestyle modification

First Posted Date: 2008-08-19

Last Posted Date: 2008-08-19

Lead Sponsor: Northwestern University

Target Recruit Count: 39

Registration Number: NCT00737347

Locations: 🇺🇸
Northwestern Memorial Hospital Wellness Institute, Chicago, Illinois, United States

Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL

Early Phase 1

Withdrawn

Conditions: Lymphoma
Neurotoxicity
Brain and Central Nervous System Tumors

First Posted Date: 2008-08-14

Last Posted Date: 2012-05-18

Lead Sponsor: Northwestern University

Registration Number: NCT00734773

The Differential Effects of 3 Different Immunosuppressive

Completed

Conditions: Kidney Transplantation
Immunosuppression

First Posted Date: 2008-08-07

Last Posted Date: 2013-08-28

Lead Sponsor: Northwestern University

Target Recruit Count: 12

Registration Number: NCT00729248

Locations: 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States

PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease)

Phase 3

Terminated

Conditions: Type 1 Diabetes

Interventions: Drug: Placebo
Drug: Ramipril

First Posted Date: 2008-08-07

Last Posted Date: 2015-03-17

Lead Sponsor: Northwestern University

Target Recruit Count: 65

Registration Number: NCT00729365

Locations: 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
Rush University Medical Center, Endocrinology Section, Chicago, Illinois, United States

and more 3 locations

Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Not Applicable

Terminated

Conditions: Hereditary Clear Cell Renal Cell Carcinoma
Kidney Cancer

Interventions: Drug: Sorafenib

First Posted Date: 2008-08-04

Last Posted Date: 2019-05-03

Lead Sponsor: Northwestern University

Target Recruit Count: 9

Registration Number: NCT00727532

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

Use of Conivaptan (Vaprisol) for Hyponatremic Neuro-ICU Patients

Phase 4

Terminated

Conditions: Hyponatremia

Interventions: Drug: Conivaptan

First Posted Date: 2008-08-01

Last Posted Date: 2022-03-28

Lead Sponsor: Northwestern University

Target Recruit Count: 6

Registration Number: NCT00727090

Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL

Not Applicable

Terminated

Conditions: Lymphoma

Interventions: Biological: Pegylated interferon α-2b
Other: Psoralens with ultraviolet light A
Other: Narrowband-ultraviolet light B

First Posted Date: 2008-07-29

Last Posted Date: 2018-12-12

Lead Sponsor: Northwestern University

Target Recruit Count: 7

Registration Number: NCT00724061

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

Effectiveness of a Technology Assisted Behavioral Intervention in Assisting People With Major Depressive Disorder

Phase 1

Completed

Conditions: Depression

Interventions: Behavioral: Treatment as usual / Wait-list control
Behavioral: Behavioral intervention (iCBT + TeleCoach)
Behavioral: Internet-based cognitive behavioral therapy (I-CBT)

First Posted Date: 2008-07-22

Last Posted Date: 2014-03-19

Lead Sponsor: Northwestern University

Target Recruit Count: 102

Registration Number: NCT00719979

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Drug: bevacizumab
Drug: erlotinib hydrochloride

First Posted Date: 2008-07-22

Last Posted Date: 2018-10-26

Lead Sponsor: Northwestern University

Target Recruit Count: 115

Registration Number: NCT00720356

Locations: 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸
Neuro-Oncology Associates at Baylor University Medical Center, Dallas, Dallas, Texas, United States
🇺🇸
Northwestern University, Northwestern Medical Faculty Foundation, Chicago, Illinois, United States

and more 6 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy